Publicacions (38) Publicacions de ANA DE LORENZO PINTO

2024

  1. Presence of metallic components in transdermal drug delivery systems and risk of skin burns

    Farmacia Hospitalaria, Vol. 48, Núm. 3, pp. T129-T132

2023

  1. Appropriateness of Empirical Antibiotic Therapy for Cervicitis and Urethritis Prescribed in the Emergency Department

    Hospital Pharmacy, Vol. 58, Núm. 1, pp. 106-110

  2. Hacia la excelencia en la atención farmacéutica al paciente quirúrgico

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. 26-30

  3. Presence of metallic components in transdermal drug delivery systems and risk of skin burns

    Farmacia Hospitalaria

2022

  1. Comparison of a polypharmacy-based scale with Charlson comorbidity index to predict 6-month mortality in chronic complex patients after an ED visit

    British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1795-1803

  2. Mobile Health Apps Providing Information on Drugs for Adult Emergency Care: Systematic Search on App Stores and Content Analysis

    JMIR mHealth and uHealth, Vol. 10, Núm. 4, pp. e29985

  3. PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort

    Biomedicine and Pharmacotherapy, Vol. 146

2021

  1. Comments on prescription of antihypertensives pro re nata

    Journal of Healthcare Quality Research

  2. La importancia de los casos clínicos para la Farmacia Hospitalaria

    Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 6, Núm. 2, pp. 1-1

2020

  1. Promoting clinical pharmacy services through advanced medication review in the emergency department

    European Journal of Hospital Pharmacy , Vol. 27, Núm. 2, pp. 73-77

2019

  1. Bolus-to-Infusion Time in Stroke Patients Treated with Alteplase on the CT Table: A Clinical Concern

    Cerebrovascular Diseases

  2. Cancellations of elective surgical procedures due to inadequate management of chronic medications

    Journal of Clinical Pharmacy and Therapeutics, Vol. 44, Núm. 4, pp. 561-564

  3. Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia

    International Journal of Clinical Pharmacy, Vol. 41, Núm. 5, pp. 1143-1147

  4. It is possible to mix insulins in the same syringe?

    Revista Clinica Espanola

  5. Thromboprophylaxis Management in Surgical Patients: The Efficacy of a Protocol in the Electronic Prescription Program

    Quality management in health care, Vol. 28, Núm. 4, pp. 245-249

2018

  1. Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study

    Expert Opinion on Drug Safety, Vol. 17, Núm. 3, pp. 235-241

2017

  1. Análisis de los resultados económicos y en salud de un programa dirigido a la reducción de hemorragia en pacientes con síndrome coronario agudo

    Revista Espanola de Cardiologia, Vol. 70, Núm. 10, pp. 825-831

  2. Enemas de lactulosa para el tratamiento de la encefalopatía hepática. ¿Ayudamos o empeoramos?

    Revista Espanola de Enfermedades Digestivas

  3. Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project

    International Journal of Clinical Practice, Vol. 71, Núm. 8

  4. Iniciativas para conseguir una atención excelente en el síndrome coronario agudo. Respuesta

    Revista Espanola de Cardiologia